NETHERLANDS TRANSLATIONAL RES CENTER B V has a total of 31 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2015. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and measurement are BESHORE DOUGLAS C, MORPHIC THERAPEUTIC INC and CURTANA PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | United States | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Canada | 3 | |
#5 | China | 3 | |
#6 | Republic of Korea | 3 | |
#7 | Australia | 2 | |
#8 | Mexico | 2 | |
#9 | Brazil | 1 | |
#10 | Hungary | 1 | |
#11 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Zaman Guido Jenny Rudolf | 28 |
#2 | De Man Adrianus Petrus Antonius | 28 |
#3 | Uitdehaag Joost Cornelis Marinus | 27 |
#4 | Buijsman Rogier Christian | 21 |
#5 | Sterrenburg Jan Gerard | 21 |
#6 | De Wit Joeri Johannes Petrus | 21 |
#7 | Van Doornmalen Antonius Maria | 14 |
#8 | Seegers Nicole Wilhelmina Cornelia | 14 |
#9 | Buijsman Rogier Christiaan | 7 |
#10 | De Roos Jeroen | 7 |
Publication | Filing date | Title |
---|---|---|
WO2019043103A1 | 3-hydroxy-imidazolidin-4-one compounds as inhibitors of indoleamine 2,3-dioxygenase | |
US2019055213A1 | Inhibitors of indoleamine 2,3-dioxygenase | |
EP3269714A1 | Inhibitors of tryptophan 2,3-dioxygenase | |
WO2016166255A1 | Prognostic biomarkers for ttk inhibitor chemotherapy | |
US2017096432A1 | (5,6-dihydro)pyrimido[4,5-E]indolizines |